Ran this query thruChatGPT said:"Using industry norms of pe what whould such a resource if developed equate to as share priceGreat question — estimating a share price impact based on contingent resource value involves a few key steps, using industry norms such as P/E multiples and adjusting for development stage, costs, and dilution. Let’s walk through a realistic, high-level valuation-to-share price estimate for Red Sky.
Assumptions & Inputs
Here’s what we’ll use as a base case:
Variable Assumption 1 Red Sky's Resource Value (2C) AUD $214.2 million (from previous table) 2 Development Cost / CapEx AUD $80 million (example assumption) 3 Net Value After Costs (NPV) AUD $134.2 million (214.2 - 80) 4 P/E Ratio (Industry Norm) 8× to 12× (for mid-cap E&P companies) 5 Shares on Issue 6 billion (example – confirm for accuracy) 6 Probability of Development 60% (to risk-adjust the valuation) Calculation Steps
1. Risk-Adjusted Net Value
Risked NPV=134.2M×0.60=AUD 80.52M\text{Risked NPV} = 134.2M \times 0.60 = \text{AUD } 80.52MRisked NPV=134.2M×0.60=AUD 80.52M2. Earnings Estimate (simplified)
Let’s say the project generates AUD $10–15M annual profit post-tax. Applying a P/E multiple of 10x:
Implied Market Cap Increase=10M×10=AUD 100M\text{Implied Market Cap Increase} = 10M \times 10 = \text{AUD } 100MImplied Market Cap Increase=10M×10=AUD 100M3. Impact on Share Price
Share Price Increase=100M6B shares=AUD 0.0167(or1.67cents)\text{Share Price Increase} = \frac{100M}{6B \text{ shares}} = \text{AUD } 0.0167 (or 1.67 cents)Share Price Increase=6B shares100M=AUD 0.0167(or1.67cents)Estimated Share Price Range (Post-Development)
Scenario Implied Market Cap Gain Per Share Value 1 Conservative (Low) AUD 80M 1.33 cents 2 Base Case (Mid) AUD 100M 1.67 cents 3 Upside (High Profit) AUD 150M 2.50 cents
- Forums
- ASX - By Stock
- ROG
- Ann: Maiden Resource Estimates Offshore Angola
ROG
red sky energy limited.
Add to My Watchlist
0.00%
!
0.4¢

Ann: Maiden Resource Estimates Offshore Angola, page-11
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.68M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
55 | 81720215 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 18987487 | 19 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
55 | 81720215 | 0.004 |
28 | 79427017 | 0.003 |
10 | 34690022 | 0.002 |
11 | 57249999 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 18987487 | 19 |
0.006 | 23605177 | 24 |
0.007 | 14148851 | 14 |
0.008 | 21567120 | 11 |
0.009 | 9070666 | 9 |
Last trade - 16.21pm 27/06/2025 (20 minute delay) ? |
Featured News
ROG (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online